TIMD4 Antikörper
Kurzübersicht für TIMD4 Antikörper (ABIN7231818)
Target
Alle TIMD4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-TIMD4 Polyclonal Antibody
-
Spezifität
- The antibody detects endogenous levels of TIMD4 protein
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human TIMD4 protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- TIMD4 (T-Cell Immunoglobulin and Mucin Domain Containing 4 (TIMD4))
-
Andere Bezeichnung
- TIMD4
-
Hintergrund
- T-cell immunoglobulin mucin receptor 4, TIM-4, T-cell membrane protein 4TIMD4 (T-Cell Immunoglobulin And Mucin Domain Containing 4) is a Protein Coding gene. Diseases associated with TIMD4 include Histiocytic Sarcoma. Among its related pathways are T Cell Co-Signaling Pathway: ligand-Receptor Interactions. An important paralog of this gene is HAVCR1. Phosphatidylserine receptor that enhances the engulfment of apoptotic cells. Involved in regulating T-cell proliferation and lymphotoxin signaling. Ligand for HAVCR1/TIMD1 (By similarity).
-
Molekulargewicht
- 41kD
-
Gen-ID
- 91937
-
UniProt
- Q96H15
-
Pathways
- Cancer Immune Checkpoints
Target
-